Personnel change in the Klinik Hirslanden management

Dietmar Mauer (62) has managed Klinik Hirslanden since 2017. Prior to this, the qualified specialist in anaesthesiology and intensive care medicine served as the hospital’s Medical Director for five years. Prior to working at Hirslanden, Dietmar Mauer was responsible for central project management and corporate development at Saarland University Hospital. Before that, he was the Managing Physician of the German Organ Transplantation Foundation (Central Region).

Working in a challenging environment, Dietmar Mauer played a decisive role in ensuring a successful course for Klinik Hirslanden in the past few years. Particular highlights include the partnership with medical professionals, the strengthening of highly specialised medicine, and the development of medical quality programmes, such as certified tumour centres. He also decisively expedited the further development of the medical system and the performance management process. In addition to his role as Hospital Manager, Dietmar Mauer sat on the Operations Committee of the Hirslanden Private Hospital Group and is well acquainted with the Group’s strategy. From September, he will be responsible for strategic tasks at Hirslanden Group level, such as the development of healthcare networks and cooperation programmes with other service providers.

“I can look back on a fulfilling time at Klinik Hirslanden, first as Medical Director and then as Hospital Manager. High quality and the well-being of the patients, employees and doctors always took centre stage for me. I’m convinced that Marco Gugolz and the management team will successfully continue this course. I now look forward to applying my experience in the development of strategic initiatives in different regions in Switzerland.”

His successor Marco Gugolz (44) has been working for Swiss Medical Network for the past seven years. He currently serves as Regional Director and is a member of the extended Executive Committee. In this function he is responsible for the private hospitals Bethanien, Lindberg and Belair, Rosenklinik and the Oerlikon medical centre. Before joining Swiss Medical Network he worked as Deputy Head of Services at Klinik Hirslanden from 2001 to 2006, and as Head of Operations & Services and a member of the executive management of Hirslanden Klinik St. Anna in Lucerne from 2006 to 2013.

Marco Gugolz has in-depth knowledge of the Swiss healthcare system and is very familiar with the hospital market in Zurich. He has broad-based experience and completed a number of advanced training and education courses. He will take on his new role on 1 September 2020.

The Executive Committee of the Hirslanden Private Hospital Group would like to thank Dietmar Mauer for his excellent contribution as Hospital Manager of Klinik Hirslanden and is pleased that it will continue to have access to his proven expertise at Group level. The Executive Committee extends a warm welcome to Marco Gugolz and wishes him much success in his future career.

About Hirslanden

The Hirslanden Private Hospital Group consists of 17 hospitals in 10 cantons, many of which have an emergency department. The Group also operates 3 outpatient clinics, 2 outpatient surgery units, 17 radiology institutes and 5 radiotherapy institutes. The Group has 2,303 affiliated doctors and 10,442 employees, of whom 510 are permanently employed doctors. Hirslanden is the leading private hospital group and the largest medical network in Switzerland. In the 2018/19 financial year, the Group generated turnover of CHF 1,778 million. As at 31 March 2019, the Group had treated 106,851 patients, amounting to a total of 479,631 inpatient days. In insurance terms, the patient mix consists of 48.7% basic, 29.5% semi-private, and 21.8% private insured patients. The Hirslanden Private Hospital Group stands for first-class medical quality, delivered by qualified medical specialists with years of experience. As a system provider, Hirslanden stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes make it possible to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Private Hospital Group was formed in 1990 through the merger of several Swiss private hospitals. Since 2007 it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.